Johnson Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
96,505
-3,368
-3% -$394K 0.09% 141
2026
Q1
$12M Sell
99,873
-3,968
-4% -$458K 0.1% 134
2025
Q4
$10.9M Sell
103,841
-6,592
-6% -$619K 0.09% 128
2025
Q3
$9.27M Buy
110,433
+659
+0.6% +$54.3K 0.08% 132
2025
Q2
$8.69M Sell
109,774
-11,817
-10% -$939K 0.08% 134
2025
Q1
$10.9M Buy
121,591
+19,118
+19% +$1.78M 0.11% 116
2024
Q4
$10.2M Sell
102,473
-1,292
-1% -$133K 0.1% 118
2024
Q3
$11.8M Buy
103,765
+6,527
+7% +$775K 0.12% 112
2024
Q2
$12M Sell
97,238
-1,109
-1% -$143K 0.13% 104
2024
Q1
$13M Sell
98,347
-1,005
-1% -$124K 0.14% 103
2023
Q4
$10.8M Buy
99,352
+2,121
+2% +$220K 0.13% 104
2023
Q3
$10M Sell
97,231
-4,444
-4% -$479K 0.13% 104
2023
Q2
$11.7M Buy
101,675
+3,199
+3% +$363K 0.15% 96
2023
Q1
$10.5M Sell
98,476
-1,022
-1% -$110K 0.14% 96
2022
Q4
$11M Sell
99,498
-1,237
-1% -$126K 0.15% 93
2022
Q3
$8.68M Sell
100,735
-1,349
-1% -$120K 0.13% 103
2022
Q2
$9.31M Buy
102,084
+2,438
+2% +$216K 0.13% 103
2022
Q1
$8.25M Buy
99,646
+11,901
+14% +$938K 0.1% 119
2021
Q4
$6.79M Buy
87,745
+555
+0.6% +$44.2K 0.08% 128
2021
Q3
$6.61M Sell
87,190
-3,603
-4% -$274K 0.09% 124
2021
Q2
$7.12M Buy
90,793
+560
+0.6% +$41.7K 0.1% 117
2021
Q1
$6.69M Buy
90,233
+3,483
+4% +$257K 0.1% 121
2020
Q4
$6.83M Buy
86,750
+2,103
+2% +$161K 0.11% 106
2020
Q3
$6.75M Sell
84,647
-2,639
-3% -$207K 0.13% 105
2020
Q2
$6.49M Sell
87,286
-5,104
-6% -$384K 0.13% 101
2020
Q1
$6.84M Sell
92,390
-1,665
-2% -$131K 0.15% 97
2019
Q4
$8.22M Sell
94,055
-1,934
-2% -$159K 0.15% 98
2019
Q3
$7.76M Buy
95,989
+65
+0.1% +$5.21K 0.15% 97
2019
Q2
$7.67M Buy
95,924
+5,736
+6% +$439K 0.16% 98
2019
Q1
$7.16M Buy
90,188
+2,505
+3% +$187K 0.15% 102
2018
Q4
$6.39M Buy
87,683
+4,274
+5% +$302K 0.16% 103
2018
Q3
$5.65M Buy
83,409
+6,447
+8% +$411K 0.13% 117
2018
Q2
$4.46M Sell
76,962
-6,946
-8% -$392K 0.11% 124
2018
Q1
$4.36M Sell
83,908
-3,380
-4% -$183K 0.11% 121
2017
Q4
$4.69M Sell
87,288
-4,652
-5% -$258K 0.12% 122
2017
Q3
$5.62M Buy
91,940
+2,842
+3% +$172K 0.15% 110
2017
Q2
$5.45M Buy
89,098
+2,774
+3% +$169K 0.15% 107
2017
Q1
$5.23M Sell
86,324
-469
-0.5% -$28.5K 0.15% 108
2016
Q4
$4.88M Buy
86,793
+7,928
+10% +$464K 0.15% 111
2016
Q3
$4.7M Buy
78,865
+3,237
+4% +$189K 0.15% 107
2016
Q2
$4.16M Sell
75,628
-161
-0.2% -$8.57K 0.14% 114
2016
Q1
$3.83M Buy
75,789
+2,665
+4% +$131K 0.13% 113
2015
Q4
$3.69M Sell
73,124
-475
-0.6% -$23.9K 0.13% 118
2015
Q3
$3.47M Buy
73,599
+834
+1% +$44.3K 0.13% 123
2015
Q2
$3.95M Buy
72,765
+2,148
+3% +$120K 0.13% 115
2015
Q1
$3.87M Buy
70,617
+5,607
+9% +$317K 0.13% 117
2014
Q4
$3.52M Buy
65,010
+1,074
+2% +$59.8K 0.12% 123
2014
Q3
$3.62M Sell
63,936
-2,555
-4% -$143K 0.12% 114
2014
Q2
$3.67M Buy
66,491
+1,847
+3% +$101K 0.13% 104
2014
Q1
$3.5M Sell
64,644
-7,979
-11% -$413K 0.13% 101
2013
Q4
$3.47M Buy
72,623
+2,924
+4% +$134K 0.13% 105
2013
Q3
$3.17M Buy
69,699
+385
+0.6% +$17.6K 0.13% 107
2013
Q2
$3.07M Buy
+69,314
New +$3.1M 0.13% 104

Other funds holding MRK

Johnson Investment Counsel's MRK Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Merck (MRK) stake by 3.4% in Q2 2026, selling an estimated $394K and leaving 96,505 shares worth $12.4M. The position accounts for 0.09% of the portfolio, ranked #141.

Johnson Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $13M in Q1 2024. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Johnson Investment Counsel held 96,505 shares of Merck worth $12.4M as of Q2 2026.
  • Johnson Investment Counsel sold 3,368 Merck shares in Q2 2026, an estimated $394K.
  • Merck made up 0.09% of Johnson Investment Counsel's portfolio in Q2 2026, its #141 holding.
  • Johnson Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Johnson Investment Counsel's Merck position peaked at $13M in Q1 2024.
  • 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.